On June 24, 2025, the "23rd World Pharmaceutical Raw Materials China Exhibition" and "18th World Pharmaceutical Machinery, Packaging Equipment & Materials China Exhibition" commenced at the Shanghai New International Expo Center. At the exhibition site, domestic and international merchants came in a steady stream, creating a bustling atmosphere. The fervor of trade and commerce surged, as all joined together to celebrate the grand event of the pharmaceutical industry.

Morimatsu has conducted an in-depth analysis of industry trends and captured market signals. It has brought innovative technologies, advanced equipment, cutting-edge design concepts, and solutions to the scene, accelerating the pace of upgrading and innovation in the global pharmaceutical manufacturing industry.

1.Solid Preparation Process Solution

The Multi-functional Fluidized Bed is equipped with easily interchangeable product pot modules, enabling multifunctional granulation, drying, and coating operations on a single machine. This ensures flexibility for product development and process improvement.

The Wet Granulator with smooth speed control provides precise parameters for operation; the switchable product pot module may meet your needs for different throughputs in experiments.

2.API Process Solution

The Multi-functional Filter-Dryer integrates filtration, washing, and drying within a single unit, streamlining processes with full automation to boost efficiency and prevent contamination.

3.Downstream Separation and Purification Solution
Single-use Online Formulation/Lysis System meets IC/ID/LS process requirements, compatible with diverse production scales, featuring modular integrated design and high-precision system configuration.

Our Intelligent Microfluidic Synthesizer serves the R&D of nano drug delivery system. Featured intelligent operation and smooth chip simulation support, it can help customers efficiently screen and optimize formulations, reduce test costs and accelerate optimization progress.

4.Lyophilization System Solution
Morimatsu's lyophilization production line, with the core concept of integrating functional units, organically integrates modules such as lyophilizers, in-feed and out-feed systems, Grade A environmental barrier systems, and filling systems. It achieves three major technological breakthroughs: flexible adaptability, high efficiency and energy saving, as well as intelligent control. It also provides dual-engine support of equipment + services.

During the exhibition, Morimatsu explored innovative pathways in the pharmaceutical industry with peers, connected global collaboration opportunities, and tapped into new industrial momentum, striving to meet growing market demands amid rapidly evolving competition and promote healthy industry development.

In the tide of internationalization and high-quality development of the pharmaceutical industry, innovative drugs and biopharmaceuticals have become new drivers of export growth, propelling more enterprises to accelerate forward in new fields and on new tracks. Morimatsu actively expands international markets, unlocks cutting-edge business opportunities, and delivers innovative, efficient product solutions, making outstanding contributions to global human health and well-being.

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services. 

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacture plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.   

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.